A phase I study of monohydroxyethylrutoside in healthy volunteers.

Cancer chemotherapy and pharmacology

Volumn 57, Issue 5, 2006, Pages 678-684

  Willems, Anja M ^a   Bruynzeel, Anne M ^a   Kedde, Marc A ^a   van Groeningen, Cees J ^a   Bast, Aalt ^a   van der Vijgh, Wim J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MONOXERUTIN;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEASIBILITY STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SAFETY; SINGLE BLIND PROCEDURE; URINALYSIS; VOLUNTARY WORKER;

ADOLESCENT; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEASIBILITY STUDIES; FEMALE; HUMANS; HYDROXYETHYLRUTOSIDE; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; SAFETY; SINGLE-BLIND METHOD; URINALYSIS; VOLUNTARY WORKERS;

EID: 33645644379     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0083-7     Document Type: Article

References (0)